Envela Corporation (ELA) Income Statement

The trajectory from 2024Q1 through 2026Q1 shows a consistent reacceleration cycle, with growth moving from negative territory into the 20-30% range through 2025 and then spiking above 60% in the back half. However, the 103.9% print in 2026Q1 appears to reflect an outsized comparison base or a non-recurring volume event, and the immediate reversion to 3.5% in 2026Q2 suggests that pace was not durable. Investors should monitor whether the 2026Q2 growth rate represents a new normalization floor or the beginning of a contraction, as the sequential revenue decline from $98.4M to $56.8M is substantial even accounting for seasonality.

The margin compression appears to have accelerated during the highest-growth quarters — 2025Q4 posted the lowest gross margin at 20.5% when revenue grew 66.6%, suggesting the incremental revenue was sourced at thinner unit economics, potentially through lower-margin product mix or promotional pricing. While margins partially recovered to 23.6% by 2026Q2, they remain well below the 24-26% range sustained in 2024, implying that the growth achieved may have come at a structural cost to profitability. Relative to specialty retail peers like EZPW at 58.5% gross margin, ELA's sub-24% profile indicates a business model heavily weighted toward cost-of-goods sensitivity rather than pricing power.

SG&A of $8.4-9.1M through most of 2024-2025 barely moved as revenue climbed from $39.9M to $98.4M, meaning each incremental revenue dollar flowed disproportionately to operating income — a pattern that took operating income from $1.9M to $11.2M at the peak. However, the 2026Q2 operating margin of 9.0% on revenue of just $56.8M shows that the leverage works in reverse: with SG&A holding at $7.8M, the revenue decline immediately compressed operating income to $5.1M from $11.2M. This asymmetry suggests the cost base is stickier than it appeared during the growth phase, and investors should treat the peak operating margin as less repeatable than the headline trend implies.

The absence of R&D spending and stock-based compensation means the entire operating cost structure is essentially COGS plus SG&A, simplifying the margin equation but also limiting levers management can pull if revenue contracts. SG&A actually declined from $9.1M in 2024Q2 to $7.8M in 2026Q2, which may indicate deliberate overhead trimming or simply natural variation — the data does not distinguish between these. With COGS consuming 74-80% of revenue across every period, ELA's fundamental cost risk remains concentrated in inventory procurement and product costs rather than discretionary spending, making gross margin the critical variable to monitor.

What makes 2025Q4 significant is that it demonstrated the business could absorb its worst gross margin of the decade and still generate meaningful operating income growth purely through volume — a capability that had not been proven in prior quarters. This quarter also set the stage for the 2026Q1 peak of $11.2M operating income, suggesting the operational infrastructure was scaled to handle elevated throughput. The lasting impact appears in the 2026Q2 reversal: with revenue falling back to $56.8M, operating income dropped to $5.1M, revealing that the profitability achieved at scale was substantially volume-dependent rather than structurally embedded in the cost base.